Basics |
Company: |
Oragenics Inc. |
IPO Date: |
March 1, 2004 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$3.92M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.09 | 5.46%
|
Avg Daily Range (30 D): |
$0.03 | 6.73%
|
Avg Daily Range (90 D): |
$0.02 | 6.02%
|
Institutional Daily Volume |
Avg Daily Volume: |
.14M |
Avg Daily Volume (30 D): |
8.13M |
Avg Daily Volume (90 D): |
3.22M |
Trade Size |
Avg Trade Size (Sh.): |
54 |
Avg Trade Size (Sh.) (30 D): |
651 |
Avg Trade Size (Sh.) (90 D): |
645 |
Institutional Trades |
Total Inst.Trades: |
14 |
Avg Inst. Trade: |
$.83M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.01M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.67M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
11.42K |
|
|
|
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-.38
|
$-.51
|
$-.7
|
Diluted EPS
|
$-.38
|
$-.51
|
$-.7
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -2.46M
|
$ -2.31M
|
$ -2.45M
|
Operating Income / Loss
|
$ -2.44M
|
$ -2.31M
|
$ -2.46M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
Splits |
Jan 23, 2023:
60:1
|
Jan 22, 2018:
10:1
|
Sep 28, 2010:
20:1
|
|